Olivia Belbin

Sant Pau Memory Unit, Universitat Autònoma de Barcelona

Affiliated withUniversitat Autònoma de Barcelona Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED)

Research Area

Neuroscience

Biography

Olivia Belbin has not added Biography.
If you are Olivia Belbin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 16	2022

Other Publications

Article	Year
Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis. PloS one\| PubMed ID: 24069280	2013
Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production. Journal of neurochemistry\| PubMed ID: 24117942	2014
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies. Journal of neuropathology and experimental neurology\| PubMed ID: 24226269	2013
Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility. Molecular neurodegeneration\| PubMed ID: 25881291	2015
Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility. Molecular neurodegeneration\| PubMed ID: 26399695	2015
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies. Journal of neuroinflammation\| PubMed ID: 28599675	2017
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies. Brain : a journal of neurology\| PubMed ID: 29177427	2017
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease. Oncotarget\| PubMed ID: 29285207	2017
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Molecular & cellular proteomics : MCP\| PubMed ID: 30606734	2019
Nanoscale structure of amyloid-β plaques in Alzheimer's disease. Scientific reports\| PubMed ID: 30914681	2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alzheimer's & dementia (New York, N. Y.)\| PubMed ID: 31650016	2019
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet (London, England)\| PubMed ID: 32593336	2020
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 32669313	2020
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular neurodegeneration\| PubMed ID: 32807227	2020
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's disease. Neurobiology of aging\| PubMed ID: 33303219	2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. Journal of neurology, neurosurgery, and psychiatry\| PubMed ID: 34103344	2021
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome. Alzheimer's research & therapy\| PubMed ID: 34183050	2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. JAMA neurology\| PubMed ID: 34228042	2021
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome. Nature communications\| PubMed ID: 34262030	2021
Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat. Neuropathology and applied neurobiology\| PubMed ID: 34825396	2022
Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Translational neurodegeneration\| PubMed ID: 34893073	2021
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone. Alzheimer's research & therapy\| PubMed ID: 35105351	2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in neurology\| PubMed ID: 35115992	2021
Fluid markers of synapse degeneration in synucleinopathies. Journal of neural transmission (Vienna, Austria : 1996)\| PubMed ID: 35147800	2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. Journal of neural transmission (Vienna, Austria : 1996)\| PubMed ID: 35169889	2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular neurodegeneration\| PubMed ID: 35395770	2022
Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA network open\| PubMed ID: 35604690	2022
Myelin loss in C9orf72 hexanucleotide expansion carriers. Journal of neuroscience research\| PubMed ID: 35766328	2022